Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F K Askari

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Hepatology (Baltimore, Md.)|June 1, 1995
Molecular mechanism of hepatocellular injury in alpha 1 antitrypsin deficiencyF K Askari
The New England Journal of Medicine|February 1, 1996
Antisense-oligonucleotide therapyF K Askari, W M McDonnell
JAMA|December 13, 1997
ImmunizationW M McDonnell, F K Askari
The New England Journal of Medicine|January 4, 1996
DNA vaccinesW M McDonnell, F K Askari
FEBS Letters|March 17, 1997
Augmentation of ouabain sensitivity of rat liver Na/K-ATPase by in vivo adenovirus-mediated expression of the Na/K-ATPase alpha2 subunitF K Askari, Y Hitomi, Z Xie
Biochemical Pharmacology|February 23, 1996
Identification of bilirubin UDP-GTs in the human alimentary tract in accordance with the gut as a putative metabolic organW M McDonnell, E Hitomi, F K Askari
Somatic Cell and Molecular Genetics|November 1, 1992
Targeted delivery of antisense oligonucleotides by molecular conjugatesB A Bunnell, F K Askari, J M Wilson
Gene Therapy|May 1, 1996
Complete correction of hyperbilirubinemia in the Gunn rat model of Crigler-Najjar syndrome type I following transient in vivo adenovirus-mediated expression of human bilirubin UDP-glucuronosyltransferaseF K Askari, Y Hitomi, M Mao, et al.
Journal of Viral Hepatitis|January 1, 1995
Sequence analysis of the hepatitis C virus (HCV) core gene suggests the core protein as an appropriate target for HCV vaccine strategiesY Hitomi, W M McDonnell, A A Killeen, et al.
Viral Immunology|January 1, 1995
High efficiency prokaryotic expression and purification of a portion of the hepatitis C core protein and analysis of the immune response to recombinant protein in BALB/c miceY Hitomi, W M McDonnell, J R Baker, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Hepatology (Baltimore, Md.)|June 1, 1995
Molecular mechanism of hepatocellular injury in alpha 1 antitrypsin deficiencyF K Askari
The New England Journal of Medicine|February 1, 1996
Antisense-oligonucleotide therapyF K Askari, W M McDonnell
JAMA|December 13, 1997
ImmunizationW M McDonnell, F K Askari
The New England Journal of Medicine|January 4, 1996
DNA vaccinesW M McDonnell, F K Askari
FEBS Letters|March 17, 1997
Augmentation of ouabain sensitivity of rat liver Na/K-ATPase by in vivo adenovirus-mediated expression of the Na/K-ATPase alpha2 subunitF K Askari, Y Hitomi, Z Xie
Biochemical Pharmacology|February 23, 1996
Identification of bilirubin UDP-GTs in the human alimentary tract in accordance with the gut as a putative metabolic organW M McDonnell, E Hitomi, F K Askari
Somatic Cell and Molecular Genetics|November 1, 1992
Targeted delivery of antisense oligonucleotides by molecular conjugatesB A Bunnell, F K Askari, J M Wilson
Gene Therapy|May 1, 1996
Complete correction of hyperbilirubinemia in the Gunn rat model of Crigler-Najjar syndrome type I following transient in vivo adenovirus-mediated expression of human bilirubin UDP-glucuronosyltransferaseF K Askari, Y Hitomi, M Mao, et al.
Journal of Viral Hepatitis|January 1, 1995
Sequence analysis of the hepatitis C virus (HCV) core gene suggests the core protein as an appropriate target for HCV vaccine strategiesY Hitomi, W M McDonnell, A A Killeen, et al.
Viral Immunology|January 1, 1995
High efficiency prokaryotic expression and purification of a portion of the hepatitis C core protein and analysis of the immune response to recombinant protein in BALB/c miceY Hitomi, W M McDonnell, J R Baker, et al.
Pageof 2